Latest news from IntraBio on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/positive-data-reported-in-a-multinational-clinical-trial-investigating-new-treatment-of-niemann-pick-disease-type-c/?sc=rsin /articles/positive-data-reported-in-a-multinational-clinical-trial-investigating-new-treatment-of-niemann-pick-disease-type-c/?sc=rsin Mon, 05 Oct 2020 05:00:58 EST A multinational clinical trial of for the treatment of Niemann-Pick disease Type C (NPC) demonstrated a statistically significant and clinically meaningful improvement in symptoms, functioning, and quality of life in both primary and topline secondary endpoints for both pediatric and adult patients with NPC. IntraBio /articles/intrabio-announces-clinical-results-for-lewy-body-dementia/?sc=rsin /articles/intrabio-announces-clinical-results-for-lewy-body-dementia/?sc=rsin Wed, 28 Nov 2018 07:00:00 EST Clinical Studies in Patients using IB1000s with Lewy Body Dementia and Fronto-Temporal Dementia Showed Marked Improvement in Quality of Life, Cognition, Mobility, Speech, and a Disease-Modifying Effect IntraBio